V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016850 | 270014666 | 0 | 67 | Curative (C) | 2016-12-16 | 2016-12-20 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270017382 | CARBOPLATIN |
| 270016851 | 270009994 | 1.7 | 66 | Curative (C) | 2013-12-22 | 2013-12-24 | VEPEMB | null | null | 270017386 | VEPEMB |
| 270016852 | 270009995 | 1.76 | 46 | Neo-adjuvant (N) | 2018-09-30 | 2018-10-08 | CISPLATIN + GEMCITABINE | 02 | N | 270017392 | CISPLATIN |
| 270016853 | 270009997 | 1.72 | 79.7 | Curative (C) | 2017-01-20 | 2017-01-25 | Irinotecan 14day | 02 | N | 270017404 | IRINOTECAN |
| 270016854 | 270014670 | 1.74 | 63 | Curative (C) | null | 2016-07-03 | Cyclophosphamide High Dose | N | null | 270017409 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016855 | 270010001 | 1.86 | null | Curative (C) | 2018-07-23 | 2018-10-30 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270017410 | CISPLATIN |
| 270016856 | 270010004 | null | 100 | Curative (C) | 2014-10-18 | 2014-10-19 | IVE | 02 | Y | 270017416 | IVE |
| 270016857 | 270010006 | 1.83 | 100.4 | Curative (C) | 2014-04-17 | 2014-04-17 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017425 | VINBLASTINE |
| 270016858 | 270010007 | 1.72 | null | Curative (C) | 2015-09-17 | 2015-09-23 | CARBOPLATIN | N | N | 270017427 | CISPLATIN + GEMCITABINE |
| 270016859 | 270010011 | 1.89 | 54 | Curative (C) | null | 2016-06-21 | CISPLATIN + GEMCITABINE | N | N | 270017430 | CISPLATIN |
| 270016860 | 270014675 | 1.68 | 80.6 | Curative (C) | null | 2015-01-29 | Irinotecan | null | null | 270017431 | IRINOTECAN |
| 270016862 | 270010021 | 1.75 | 90 | Curative (C) | null | 2013-12-31 | Cisplatin 7 day | null | Y | 270017436 | VEPEMB |
| 270016863 | 270018478 | 1.73 | null | Curative (C) | null | 2018-06-27 | Cyclophosphamide High Dose | 02 | N | 270017438 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016864 | 270010027 | 1.66 | 69.8 | null | 2017-09-26 | 2017-09-26 | GEM-P | 02 | N | 270017449 | GEMCITABINE + PACLITAXEL |
| 270016865 | 270010028 | 1.71 | 66.9 | Curative (C) | 2014-03-12 | 2014-03-18 | GEM-P | N | N | 270017455 | GEMCITABINE + PACLITAXEL |
| 270016866 | 270010030 | 1.86 | 75.3 | Palliative (P) | 2017-01-25 | 2017-02-15 | GDP | N | null | 270017456 | GDP |
| 270016867 | 270010033 | 1.78 | 63 | Curative (C) | 2018-02-27 | 2018-03-02 | Irinotecan | 2 | N | 270017457 | IRINOTECAN |
| 270016868 | 270017104 | 0 | 90.8 | Curative (C) | 2014-11-08 | 2014-11-10 | Panitumumab | 2 | N | 270017460 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016869 | 270010036 | 1.65 | 63 | Curative (C) | 2014-04-06 | 2014-11-30 | Irinotecan | 02 | null | 270017468 | IRINOTECAN |
| 270016870 | 270017105 | 1.55 | 69.8 | Curative (C) | 2014-06-05 | 2014-06-12 | IVE | 2 | N | 270017469 | IVE |
| 270016871 | 270014689 | 1.73 | 77 | Curative (C) | 2016-09-21 | 2018-08-13 | Cisplatin | N | null | 270017473 | GEMCITABINE |
| 270016874 | 270010050 | 1.8 | 80.3 | Adjuvant (A) | 2015-11-02 | 2015-11-06 | Oxaliplatin + Raltitrexed | N | N | 270017486 | NIVOLUMAB |
| 270016875 | 270010052 | 1.58 | 59.1 | Palliative (P) | 2017-03-22 | 2017-04-29 | GEM-P | N | N | 270017488 | GEMCITABINE + PACLITAXEL |
| 270016876 | 270010055 | null | 76 | Palliative (P) | null | 2015-12-07 | BEAM + Alemtuzumab Allo SCT | N | N | 270017496 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016877 | 270010058 | 1.77 | 85.4 | Curative (C) | 2017-07-28 | 2017-07-30 | ABVD R | null | null | 270017498 | BEAM + ALEMTUZUMAB |
| 270016878 | 270010061 | 1.78 | null | Curative (C) | 2013-07-03 | 2013-07-09 | Cyclophosphamide High Dose | N | N | 270017505 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016879 | 270010066 | 1.77 | null | Palliative (P) | 2018-08-10 | 2018-12-09 | Cisplatin 7 day | 01 | null | 270017507 | VEPEMB |
| 270016880 | 270010070 | 1.65 | 90.9 | Curative (C) | 2015-07-25 | 2015-08-02 | GDP | N | N | 270017512 | GDP |
| 270016881 | 270014701 | 1.81 | 78 | Curative (C) | 2015-01-13 | 2015-09-29 | NIVOLUMAB | N | N | 270017566 | OXALIPLATIN + RALTITREXED |
| 270016882 | 270010074 | null | 73.1 | Curative (C) | 2015-05-07 | 2015-05-12 | GDP | N | null | 270017577 | GDP |
| 270016883 | 270010078 | 1.65 | 72 | Curative (C) | 2013-10-29 | 2013-11-13 | Gemcitabine + Methylprednisolone | N | null | 270017633 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016884 | 270010080 | 1.61 | null | Curative (C) | 2014-03-02 | 2014-04-05 | BEAM + Alemtuzumab Allo SCT | 01 | N | 270017635 | OXALIPLATIN + RALTITREXED |
| 270016885 | 270019264 | 1.58 | 80 | Palliative (P) | 2014-08-13 | 2014-09-28 | BENDAMUSTINE | N | null | 270017661 | BENDAMUSTINE |
| 270016886 | 270010082 | 1.65 | 74.6 | Palliative (P) | 2014-10-29 | 2014-11-03 | BEAM + Alemtuzumab Allo SCT | N | N | 270017663 | VINBLASTINE |
| 270016887 | 270014707 | 1.87 | 79.6 | Palliative (P) | 2013-10-10 | 2013-10-12 | Bendamustine +/- Prednisolone | 02 | N | 270017673 | BENDAMUSTINE |
| 270016888 | 270010085 | 1.85 | 90.3 | Curative (C) | 2013-07-04 | 2013-11-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 270017681 | VEPEMB |
| 270016889 | 270010088 | 1.77 | 43.5 | Adjuvant (A) | 2016-03-27 | 2017-02-18 | CISPLATIN + GEMCITABINE | N | N | 270017686 | NIVOLUMAB |
| 270016890 | 270010090 | 1.66 | 79.4 | Adjuvant (A) | 2018-08-13 | 2018-08-13 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270017744 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016891 | 270010093 | 1.8 | 50 | Palliative (P) | 2014-09-21 | 2014-09-21 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017783 | PANITUMUMAB |
| 270016892 | 270010094 | 1.73 | 73 | Curative (C) | 2019-03-04 | 2019-03-05 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270017787 | BEAM + ALEMTUZUMAB |
| 270016894 | 270010097 | 1.8 | 68.5 | Neo-adjuvant (N) | 2019-01-04 | 2019-01-04 | Irinotecan | N | null | 270017792 | IRINOTECAN |
| 270016895 | 270017120 | 1.65 | 83.8 | Curative (C) | 2015-03-29 | 2015-04-17 | ABVD R | N | N | 270017800 | CARBOPLATIN |
| 270016896 | 270017120 | 1.73 | 84.1 | Disease modification (D) | 2015-11-18 | 2017-04-23 | IGEV | N | N | 270017800 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016897 | 270010102 | 1.72 | 84.7 | Adjuvant (A) | 2013-09-07 | 2013-09-10 | Cisplatin+Gemcitabine (Days 1&8&15) | null | N | 270017822 | IGEV |
| 270016898 | 270017122 | 0 | 46.6 | Disease modification (D) | 2014-01-23 | 2014-05-02 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017849 | CARBOPLATIN |
| 270016899 | 270010105 | null | 57.5 | Palliative (P) | 2018-02-06 | 2018-04-06 | ABVD R | N | null | 270017876 | IGEV |
| 270016900 | 270010107 | 1.83 | 81.7 | null | 2017-05-02 | 2017-05-05 | IVE | 02 | N | 270017881 | IVE |
| 270016901 | 270010109 | 1.77 | null | Adjuvant (A) | 2015-05-12 | 2015-05-16 | GEMCITABINE | 2 | null | 270017888 | BEAM + ALEMTUZUMAB |
| 270016902 | 270010112 | 1.8 | 57 | null | 2017-10-22 | 2017-10-22 | CISPLATIN + GEMCITABINE | N | N | 270017902 | VEPEMB |
| 270016903 | 270010113 | 1.69 | 68.1 | Adjuvant (A) | 2017-08-12 | 2017-08-12 | NIVOLUMAB | N | N | 270017920 | VEPEMB |